Service Corporation International (SCI) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
16 Mar, 2026Executive summary
Achieved strong financial performance in 2025, with adjusted EPS of $3.85 and a 12% CAGR since 2019, despite macroeconomic challenges.
Returned $645 million to shareholders via dividends and share repurchases, and invested $180 million in acquisitions and new builds.
Board succession planning included nominating Carl Loredo and welcoming Thad Hill, while Alan R. Buckwalter will retire after 22 years.
Enhanced digital capabilities and technology realignment to improve client service and operational efficiency.
Maintained a preneed backlog of $17 billion, supporting future growth and stable revenue streams.
Voting matters and shareholder proposals
Election of 10 directors, including new nominee Carl Loredo.
Ratification of PricewaterhouseCoopers LLP as independent auditor.
Advisory vote on executive compensation (“say-on-pay”).
Amendments to reduce minimum board size, allow board to fill vacancies, and limit officer liability.
Approval of the 2026 Equity Incentive Plan.
Board of directors and corporate governance
9 of 10 directors are independent; board committees are fully independent.
Board refreshment since 2018 reduced average age and tenure, increased diversity, and added five new directors.
Three of four board committees are chaired by women with significant tenure.
Lead Independent Director role strengthened, with Marcus Watts appointed in 2023.
Annual board and committee evaluations, orientation, and ongoing education for directors.
Latest events from Service Corporation International
- Disciplined growth, digital innovation, and demographic tailwinds drive renewed earnings momentum.SCI
JPMorgan Industrials Conference 202617 Mar 2026 - Urban network, pre-need backlog, and tech-driven efficiency fuel growth and future outlook.SCI
47th Annual Raymond James Institutional Investor Conference3 Mar 2026 - Adjusted EPS rose 8% in Q4 and 9% for the year, with 2026 guidance targeting further growth.SCI
Q4 202513 Feb 2026 - Earnings growth, robust M&A, and tech-driven efficiency position the business for strong future gains.SCI
Raymond James & Associates’ 46th Annual Institutional Investors Conference 20253 Feb 2026 - Normalized growth, margin expansion, and evolving cremation trends shape the outlook.SCI
BofA Securities Leveraged Finance Conference 20253 Feb 2026 - Q2 revenue up, adjusted EPS down; strong cash flow and capital returns; guidance at lower end.SCI
Q2 20242 Feb 2026 - Q3 2024 delivered stable profits, strong cash flow, and record acquisitions for future growth.SCI
Q3 202417 Jan 2026 - Stabilized volumes, moderated cremation shifts, and strong pre-need sales drive 2026 growth.SCI
UBS Global Healthcare Conference 202513 Jan 2026 - Strong market position, robust cash flow, and strategic growth drive superior shareholder returns.SCI
Investor presentation13 Jan 2026